Combined therapy for incomplete heart artery opening
Part of Heart & circulation clinical trials.
This study tests a combination of two treatments to help people with coronary artery disease whose heart vessels were not fully opened. It aims to improve blood flow and reduce symptoms like chest pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have coronary artery disease and at least one heart artery is nearly completely blocked (more than 90%) and not fully opened.
- You have symptoms of reduced blood flow to the heart, such as chest pain or shortness of breath.
- You do not have severe heart failure, kidney failure requiring dialysis, or other serious conditions listed in the study.
- You are willing to participate in mindfulness therapy and follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if combining a new heart procedure with a special type of therapy called mindfulness therapy can help prevent heart problems in people with coronary artery disease that could not be fully fixed with stents or surgery.
This trial compares different ways to treat serious heart artery blockages in people with a recent heart attack or unstable chest pain. It aims to see which revascularization approach works best when doctors think the heart arteries can be fully treated.
This study tests a new stem cell treatment for people with widespread coronary artery disease (narrowing of heart blood vessels) that causes chest pain. The treatment aims to improve blood flow and reduce symptoms, even for those who are not good candidates for other procedures.
This trial studies whether two ways of threading a device to open a long-term blocked coronary artery are both safe and effective. You may qualify if you have a chronic total blockage and heart-related symptoms, and you can follow the study follow-up plan.
This trial uses a special pressure wire called RFR to help doctors decide whether a stent is needed for a moderate heart artery blockage. It aims to make sure only the blockages that really need treatment get stented, which may reduce unnecessary procedures.
This trial tests whether a non-invasive heart mapping technique can guide treatment for stable coronary artery disease, potentially avoiding more expensive or invasive tests. You may join if you have stable angina and a blockage of 50-90% in a major heart artery.
Hear when a new Coronary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.